Kimberly Rivera-Caraballo

5PUBLICATIONS
29CO-AUTHORS
Molecular targetsGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 12, 2026
Development and preclinical evaluation of a decoy DLL4-encoding oncolytic HSV-1 for high-grade glioma.

|Apr 15, 2026
PRMT5 inhibition impairs Fanconi Anemia pathway-mediated homologous recombination and enhances the antitumor efficacy of Temozolomide in glioblastoma.

|Dec 18, 2025
Oncolytic HSV-1-Mediated JAG1 Blockade Induces Glioma Senescence-Associated Secretory Phenotype to Increase Macrophage Activation and Cetuximab-Mediated Senolysis.

Kimberly A Rivera-Caraballo, Tae Jin Lee, Arnoneel Sinha

|Dec 23, 2024
Blocking Feedback Immunosuppression of Antigen Presentation in Brain Tumor During Oncolytic Virotherapy with oHSV-mshPKR.

Nobushige Tsuboi, Kimberly A Rivera-Caraballo, Upasana Sahu

|Jan 13, 2022
NOTCH-Induced MDSC Recruitment after oHSV Virotherapy in CNS Cancer Models Modulates Antitumor Immunotherapy.

Yoshihiro Otani, Ji Young Yoo, Cole T Lewis

Pageof 1

Frequent Collaborators

3 joint publications

Balveen Kaur

3 joint publications

Sara A Murphy

3 joint publications

Bangxing Hong

2 joint publications

Upasana Sahu